US$3.56 - That's What Analysts Think Agilon Health, Inc. (NYSE:AGL) Is Worth After These Results
BofA Securities Maintains Agilon Health(AGL.US) With Sell Rating, Announces Target Price $2.4
Agilon Health Faces Financial Challenges Amid Rising Costs and Enrollment Risks: Analyst Recommends Sell Rating
Agilon Health's Earnings Call: Growth Amid Challenges
Benchmark Co. Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $4
Barclays Maintains Agilon Health(AGL.US) With Sell Rating, Maintains Target Price $2
Agilon Health (AGL) Receives a Sell From Barclays
Analysts Conflicted on These Healthcare Names: Agilon Health (AGL), AN2 Therapeutics, Inc. (ANTX) and Alcon (ALC)
Cautious Hold Rating on Agilon Health Amid Uncertainty and Cost Challenges
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Agilon Health Is Maintained at Outperform by RBC Capital
$AGL Stock Is up 8% Today. Here's What We See in Our Data.
Express News | Citizens Capital Markets Reiterates Market Perform on Agilon Healthto Market Perform
Agilon Health Is Maintained at Hold by Stifel
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $5 to $5
TD Cowen Sticks to Their Hold Rating for Agilon Health (AGL)
Agilon Health Analyst Ratings
RBC Raises Price Target on Agilon Health to $3.50 From $3, Keeps Outperform Rating